As the NHS financial year draws to an end we bring together our esteemed panel of NHS commentators with specific expertise in rare diseases to help you interpret the strategic and tactical changes within the NHS and its likely impact on industry.
This timely 60-minute masterclass for LSAA members will help YOU enhance patient outcomes during 2024 and beyond.
8th Mar 2024 13:00 – 14:00 (GMT)
Speakers
Owner & Lead Consultant, Sagio Ltd
Managing Director, Oxygen Strategy
Principal Head of Market Access, IQVIA
Chief Executive Officer, Initiate
Former Member of the Board of Advisors, ATMPS | Director at NJ Redfern Ltd
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now